Wondfo
  • Home
  • About us
    About Wondfo
    About Wondfo
    Wondfo Commitment
    Wondfo Commitment
    Global Sustainability
    Global Sustainability
    Wondfo Heritage
    Wondfo Heritage
    Wondfo FAQs
    Wondfo FAQs
  • Products
    Colloidal Gold Platform
    The most developed technology platform with a variety of applications, including infectious disease detection, fertility detection, the drug of abuse detection, etc.
    Immunofluorescence Platform
    50+ kinds of reagents and three high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
    Molecular Diagnostics Platform
    Ready-to-use lyophilized RT-PCR Reagent;
    Gold Standard for COVID-19 Diagnosis
    Blood Gas Platform
    Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
    Coagulation Platform
    Wondfo optical blood coagulation analyzer is the only one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
    Chemiluminescence Platform
    Single-dose Chemiluminescense Immunoassay Platform
    Pathology Platform
    Wondfo PA-3600 IHC Staining System
    Colloidal Gold Platform
    Immunofluorescence Platform
    Molecular Diagnostics Platform
    Blood Gas Platform
    Coagulation Platform
    Chemiluminescence Platform
    Pathology Platform
  • Solutions
  • Careers
  • Resource Center
    Education & Training
    Education & Training
    Product Information
    Product Information
    COVID-19 Clinical Research
    COVID-19 Clinical Research
    COVID-19 Guideline
    COVID-19 Guideline
  • News & Press
  • Contact Us
    Contact Us
    Contact Us
    Event Registration
    Event Registration
Log in
Global
China North America Global Réponse COVID-19 Respuesta de COVID-19 Реагирования на COVID-19 COVID-19-Reaktion
  • Home
  • About us
    About Wondfo Wondfo Commitment Global Sustainability Wondfo Heritage Wondfo FAQs
  • Products
    Colloidal Gold Platform Immunofluorescence Platform Molecular Diagnostics Platform Blood Gas Platform Coagulation Platform Chemiluminescence Platform Pathology Platform
  • Solutions
    1㎡ POCT Lab COVID-19 Total Solution
  • Careers
  • Resource Center
    Education & Training Product Information COVID-19 Clinical Research COVID-19 Guideline
  • News & Press
  • Contact Us
  • National Appreciation | Wondfo Assists in AIDS Control
    AIDS Prevention and Control Center of the Healthy China Initiative is established in Wondfo
  • Wondfo Biotech Mid-Year Economic Outlook of 2022
    1.178-billion-yuan net profit attributable to the parent, registering a year-on-year growth of 112%
  • Wondfo HIV Self-Test Is Available at US$1 for LMIC
    What does the agreement mean for people from low- and middle-income countries
  • New agreement secures historic US$1 price for HIV self-test
    MedAccess, the Clinton Health Access Initiative (CHAI), and Wondfo announced an agreement to make Wondfo’s HIV self-test available for US$1.
  • Wondfo | International AIDS Conference 2022
    At booth 920, Wondfo is well-prepared for your visit
  • Wondfo HIV Self-Test Is Certified With WHO Prequalification
    Contribution to combat & control AIDS
  • Wondfo | MEDEXPO Kenya 2022
    Sarit Expo Centre, Nairobi, Kenya
  • One Step HIV-HCV-HBsAg-Syphilis Combo Test
    Wondfo One Step HIV-HCV-HBsAg-Syphilis Combo Whole Blood/Plasma/Serum Test is intended for use by healthcare professionals and as qualitative screening in vitro diagnostic test for detection of 4 immunereactants: HIV1/2 antibodies, Hepatitis C Virus (HCV) antibody, Hepatitis B surface Antigen (HBsAg) and Treponema Pallidum (TP) antibody in human whole blood/plasma/serum. This test is not automated and does not require any additional instrument.
  • World AIDS Day | Who Should Be Screened for the HIV Infection
    End Inequality with Connected Hearts
  • HIV-HCV-HBsAg Test
    Wondfo One Step HIV-HCV-HBsAg Combo Whole Blood/Plasma/Serum Test is intended for use by healthcare professionals and as qualitative screening in vitro diagnostic test for detection of 3 immunereactants: HIV1/2 antibodies, Hepatitis C Virus (HCV) antibody and Hepatitis B surface Antigen (HBsAg) in human whole blood/plasma/serum. This test is not automated and does not require any additional instrument.
Prev1234Next
load more
About us
About Wondfo
Wondfo Commitment
Global Sustainability
Wondfo Heritage
Wondfo FAQs
News & Press
Wondfo News
Medical Fairs
Blog
Products
Colloidal Gold Platform
Immunofluorescence Platform
Molecular Diagnostics Platform
Blood Gas Platform
Coagulation Platform
Chemiluminescence Platform
Pathology Platform
Solutions
1㎡ POCT Lab
COVID-19 Total Solution
Careers
Education & Training
Contact Us
Stay in touch
  • Phone : (+86) 400-830-8768
  • Email : sales@wondfo.com.cn
  • Address : No.8 Lizhishan Road, Science City, Luogang,Guangzhou, China
Follow Us
COPYRIGHT © 2020 Wondfo .ALL RIGHTS RESERVED Powered by vancheer